… that are lipid lowering agents as well (as noted in Table 2 ). … or indicated at sub-maximum
dosages for HIV patients. … to add to the evidence of the effectiveness of ezetimibe as a …

… and the most prescribed lipid-lowering agents currently available; … ezetimibe addition to
maximally tolerated statin treatment in 33 HIV patients who did not manage to achieve the LDL…

… who are taking moderate-intensity statins at a maximal … We sought to establish that adding
ezetimibe to moderate-… has been recommended as the cornerstone lipid-lowering therapy. …

… In addition to statins, other lipid lowering agents, including … ) from baseline was noted in the
ezetimibe add-on arm. In terms … tolerated or as an adjunctive treatment to maximum tolerated …

… Adding ezetimibe to PCSK9 inhibitor and statins did not … LDL-C lowering despite being
on maximally tolerated statin … with prior evidence on lipid-lowering therapies. For instance, a …

… combined with a statin.PTN AIDS allows this combination,as well as the use of ezetimibe …
who had experienced cardiovascular incidentshad statins in maximal doses. Interestingly …

… the background of maximally tolerated statin therapy. For some … patients were on stable
ART and lipid-lowering therapy and … tolerated and effective for lowering LDL-cholesterol in HIV-…

… that adding ezetimibe is the best strategy for intensifying the lipid-lowering therapy in patients
with … Adding ezetimibe to the treatment of HIV-positive patients, who could not reach their …

… Patients with HIV + status; intestinal malabsorption; … , the addition of ezetimibe to a statin
was apparently more … compared with free combinations of lipid-lowering therapy. In a large-…

… in Asia with hypercholesterolemia on lipid-lowering therapies (LLTs). In addition, the DYSIS
… These data indicate a need for more effective treatments to help more patients in Asia to …